BiotechTubeBiotechTube
Home/Pipeline/Oncology APIs & Formulations

Oncology APIs & Formulations

Cancer

Development/CommercialActive

Key Facts

Indication
Cancer
Phase
Development/Commercial
Status
Active
Company
Nectar Lifesciences

About Nectar Lifesciences

Nectar Lifesciences is a vertically integrated pharmaceutical company with a core focus on anti-infectives, especially cephalosporins and penicillins. The company has established itself as a major global API manufacturer and exporter, with a significant portfolio of over 100 products and a robust R&D pipeline. Its strategic direction involves expanding its presence in regulated markets, diversifying into new therapeutic areas like oncology and cardiology, and leveraging its manufacturing excellence for contract manufacturing opportunities.

View full company profile

Therapeutic Areas

Anti-infectivesCardiologyGastroenterologyOncologyCentral Nervous System

Other Cancer Drugs

DrugCompanyPhase
Shared Antigen mRNA Cancer VaccinesBioNTechPhase 2
Targeted Oncology TherapiesBioNTechPhase 1/2
ARGX-119ArgenxPhase 1
Oncology ProgramShionogiClinical
Bmab (Bevacizumab)BioconApproved
Ciforadenant (CPI-444)Corvus PharmaceuticalsPhase 1/2
Mupadolimab (CPI-006)Corvus PharmaceuticalsPhase 1
tovecimigCompass TherapeuticsClinical
CTX-8371Compass TherapeuticsClinical
XmAb 14045XencorClinical
XmAb 13676XencorClinical
VibostolimabXencorClinical